ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,764Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 1383

$777K Total Retail Price of All Prescriptions

Rank: 123 out of 1383

449 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 449 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 449 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 16,990 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LEVOTHYROXINE SODIUM 868 765 1 4
HYDROCODONE-ACETAMINOPHEN 824 729 S3 2 1
LISINOPRIL 776 689 3 3
METOPROLOL TARTRATE 715 644 4 9
SIMVASTATIN 599 508 5 2
FUROSEMIDE 560 494 6 7
OMEPRAZOLE 524 442 7 5
CITALOPRAM HBR 476 435 8 15
GABAPENTIN 439 391 9 11
AMLODIPINE BESYLATE 395 339 10 6
METFORMIN HCL 360 278 11 8
LOVASTATIN 328 293 12 22
POTASSIUM CHLORIDE 315 303 13 12
LANTUS 313 247 14 50
MELOXICAM 312 276 15 20
TRAZODONE HCL 290 252 16 36
FENTANYL 261 238 S2 17 92
WARFARIN SODIUM 242 241 18 13
FAMOTIDINE 225 176 19 61
PLAVIX 216 199 20 43
NYSTATIN 209 191 21 132
DONEPEZIL HCL 209 207 21 35
HYDROCHLOROTHIAZIDE 206 200 23 10
ISOSORBIDE MONONITRATE ER 191 169 24 66
SERTRALINE HCL 189 172 25 21
CLOPIDOGREL 189 174 25 28
RANITIDINE HCL 186 171 27 19
CARVEDILOL 182 156 28 24
TRAMADOL HCL 180 164 29 25
ATENOLOL 174 147 30 16
MIRTAZAPINE 164 164 31 51
NAMENDA 161 161 32 49
PANTOPRAZOLE SODIUM 158 142 33 32
NOVOLOG 157 92 34 139
TAMSULOSIN HCL 150 127 35 30
NOVOLIN R 146 134 36 167
ALENDRONATE SODIUM 145 129 37 37
PRAVASTATIN SODIUM 143 126 38 14
SPIRONOLACTONE 131 88 39 67
DIGOXIN 130 130 40 59
CYMBALTA 127 68 41 53
RISPERIDONE 124 84 42 71
ALLOPURINOL 114 106 43 33
CRESTOR 113 53 44 34
LOSARTAN POTASSIUM 111 109 45 23
METOPROLOL SUCCINATE 108 108 46 29
FLUTICASONE PROPIONATE 107 85 47 39
LYRICA 106 87 48 72
PREDNISONE 104 94 49 40
JANTOVEN 94 82 50 146
CEFTRIAXONE 89 74 51 175
IPRATROPIUM-ALBUTEROL 83 73 52 138
CLONIDINE HCL 83 70 52 44
GLIMEPIRIDE 80 63 54 31
BENAZEPRIL HCL 79 79 55 38
AZITHROMYCIN 78 71 56 41
QUETIAPINE FUMARATE 78 68 56 70
LEVOFLOXACIN 77 67 58 88
CARBIDOPA-LEVODOPA 77 76 58 108
DILTIAZEM 24HR CD 77 64 58 95
POLYETHYLENE GLYCOL 3350 75 66 61 64
MEGESTROL ACETATE 72 66 R 62 170
SEROQUEL 68 61 63 130
METHIMAZOLE 68 68 63 402
ATORVASTATIN CALCIUM 68 65 63 18
DIOVAN 67 63 66 58
PRIMIDONE 66 66 67 207
SUCRALFATE 66 51 67 190
RAMIPRIL 61 51 69 80
DOXYCYCLINE HYCLATE 60 41 70 94
HYDRALAZINE HCL 59 59 71 86
DIVALPROEX SODIUM 56 37 72 78
PROMETHAZINE HCL 55 36 R 73 56
BUMETANIDE 53 53 74 122
TERAZOSIN HCL 53 37 74 111
METHOTREXATE 53 41 74 256
ROPINIROLE HCL 53 53 74 79
KLOR-CON M20 51 46 78 100
SPIRIVA 50 43 79 45
INSULIN SYRINGE 50 26 79 83
OLANZAPINE 50 50 79 164
FLUCONAZOLE 50 44 79 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.